Guidelines

FDA guidance focuses on infections with reusable devices, including duodenoscopes

Publish date: March 18, 2015

 

References

The FDA is asking health care professionals to report any infections possibly related to ERCP duodenoscopes to the manufacturers and the FDA’s MedWatch program.

The Centers for Disease Control and Prevention has provided an interim protocol for health care facilities, with information on monitoring for bacterial contamination of duodenoscopes after reprocessing and other reprocessing issues.

emechcatie@frontlinemedcom.com

Pages

Recommended Reading

Efficacy, not tolerability, of bowel prep is primary
MDedge Internal Medicine
Bariatric surgery’s long-term durability, complications still unknown
MDedge Internal Medicine
Intragastric balloons offer weight loss surgery alternative
MDedge Internal Medicine
Early nasoenteric feeding not beneficial in acute pancreatitis
MDedge Internal Medicine
Diabetes drug liraglutide approved for weight loss indication
MDedge Internal Medicine
Bariatric surgery linked to lower mortality
MDedge Internal Medicine
FDA approves vagal blocking device for obesity
MDedge Internal Medicine
CNS stimulant is first drug approved for binge-eating disorder
MDedge Internal Medicine
No increased pancreatitis risk found with incretin therapy
MDedge Internal Medicine
AGA guideline addresses asymptomatic neoplastic pancreatic cysts
MDedge Internal Medicine